They are based on the qualitative and quantitative evaluation of biomarkers related to the atherosclerosis process—e.g., a study by Aliyeva et al. [61] assessed the presence and abundance of factors such as Il-10, TNF-alpha, and CD56+ NK (natural killer) cells. This evidence concerns the gene TNF and atherosclerosis.